1)BismuthⅣtype hilar cholangiocarcinomaBismuthⅣ型肝门部胆管癌
英文短句/例句
1.Surgical Management for Bismuth Ⅳ Type Hilar CholangiocarcinomaBismuthⅣ型肝门部胆管癌的外科治疗
2.Proliferative Effects for a Cholangiocarcinoma Cell Line of Bile From Patients with Biliary Calculi and with Bile Tract Neoplasm;成石性胆汁及胆管癌性胆汁对人肝门部胆管癌细胞增殖的影响
3.Progress and problems in surgical treatment of hilar carcinoma of the bile duct肝门部胆管癌外科治疗的进步及问题
4.Surgical treatment experiences of Bismuth type Ⅲ hilar cholangiocarcinomaBismuthⅢ型肝门胆管癌的外科治疗体会
5.The value of color Dopper ultrasonography in diagnosing hilar cholangiocarcinoma彩色多普勒超声对肝门部胆管癌的诊断价值
6.The experimental study on the mode of invasion and metastasis of hilar bile duct carcinoma肝门部胆管癌浸润与转移方式的实验研究
7.Correlative Study on MRI Findings with MVD and Expression of VEGF in Hilar Cholangiocarcinoma;肝门部胆管癌MR表现与MVD、VEGF表达的相关性研究
8.The General Study on Diagnosis and Interventional Therapy of Hilar Cholangiocarcinoma;肝门部胆管癌诊断与介入治疗的综合研究
9.Diagnosis and Surgical Treatment of 78 Patients with Hilar Cholangiocarcinoma;78例肝门部胆管癌诊断和外科治疗分析
10.Expression of hMLH1、hMSH2 and Its Correlation in Hilar Cholangiocarcinoma;HMLH1、HMSH2在肝门部胆管癌中的表达及其相关性研究
11.Study on the Expression of Ki-67、Bax and p73 in Hilar Cholagiocarcinoma;Ki-67、Bax和p73在肝门部胆管癌中的表达和意义
12.Analysis of the Relation between Surgical Procedure and Prognosis of Hilar Cholangiocarcinoma;手术方式与肝门部胆管癌预后的关系分析
13.Factors Influencing Results of Surgical Therapy for Hilar Cholangiocarcinoma;影响肝门部胆管癌外科疗效的因素分析
14.Diagnosis and Surgical Treatment for Hilar Cholangiocarcinoma: A Report of 59 Cases;肝门部胆管癌的诊断和外科治疗（附59例报告）
15.Prognostic Factors Influencing Postoperative Survival after Operation for Hilar Cholangiocarcinoma;影响肝门部胆管癌外科治疗的预后因素
16.Clinicopathologic Study on Perineural Invasion in Hilar Cholangiocarcinoma;肝门部胆管癌神经浸润的临床病理学研究
17.Clinical study of ~(125)I radioactive particles implanted to treat hilar cholangiocarcinoma~(125)I放射性粒子治疗肝门部胆管癌的临床研究
18.Tumor resectability assessment of hilar cholangiocarcinoma using imaging肝门部胆管癌可切除性的术前影像学评估
相关短句/例句
hilar cholangiocarcinoma肝门部胆管癌
1.Effect of preoperative biliary drainage on hilar cholangiocarcinoma in patients underwent resection operation;肝门部胆管癌术前减黄临床价值
2.Combined resection of the hepatic artery in hilar cholangiocarcinoma;联合肝动脉切除在肝门部胆管癌根治术中的应用
3.64-slice spiral CT 3-D angiography(CTA) and 3-D positive contrast CT cholangiography in the preoperative evaluation of patients with hilar cholangiocarcinoma;64排CT胆道和血管三维重建用于肝门部胆管癌术前评估的研究
3)Hilarbiliary carcinoma肝门部胆管胆管癌
4)hilar cholangiocarcinoma肝门胆管癌
1.Surgical treatment of hilar cholangiocarcinoma (with a report of 8 cases);肝门胆管癌的手术治疗(附8例切除报告)
2.MSCT appearance of hepatic hilar cholangiocarcinoma with pathologic correlation;肝门胆管癌的MSC对照CT表现与病理
3.Predictive factors on operative therapy of the hilar cholangiocarcinoma;影响手术治疗肝门胆管癌预后的多因素分析
5)hepatic hilar cholangiocarcinoma肝门胆管癌
1.Methods: 70 cases were treated with PTC by puncturing the left duct (22 cases were the hepatic hilar cholangiocarcinoma ) , 6 1 cases were successfully punctured (a successful ratio is 87.方法:本组70例行左肝管定向穿刺胆管造影术(其中22例肝门胆管癌),61例穿刺成功,成功率87。
2.Objective: To study the value of percutaneous transhepatic cholangiography(PTC) in typical diagnosis of hepatic hilar cholangiocarcinoma.目的 :探讨经皮肝穿刺胆道造影术 (PTC)在肝门胆管癌分型诊断中的作用。
6)Hilar carcinoma of bile duct/Klaskin tumor肝门部胆管癌/Klaskin瘤
延伸阅读
bismuth 铋元素符号Bi，原子序数83，原子量208.98，外围电子排布6s26p3，位于第六周期第ⅤA族，共价半径152皮米，离子半径Bi3+120皮米，Bi5+74皮米，第一电离能703.3千焦/摩尔，电负性1.9。银白色或微红色有金属光泽的晶体，熔点271.4℃，沸点1560±5℃，蒸气分子中单原子分子和双原子分子处于平衡状态。主要氧化数-3、+1、+3、+5。色的无定形锑，黄色的黄锑，黑色的黑锑等。锑化学性质不很活动。室温下不能被空气中氧气氧化，但能跟氟、氯、溴化合生成三价或五价卤化物。加热时可跟碘、硫化合。高温时燃烧显蓝色并生成Sb4O6。常温时不跟水反应，红热时跟水反应放出氢气。跟热硝酸反应，生成水合氧化锑： 6Sb+10HNO3+3xH2O=3Sb2O5·xH2O+10NO↑+5H2O 能溶于热的浓盐酸和硫酸生成氯化锑和硫酸锑。与强碱反应生成亚锑酸盐，主要用于制合金如印刷用的活字合金、硬质合金、巴氏合金。还用于制锑盐、医药、颜料及半导体材料等。古代已应用锑及其化合物。在自然界中有游离态和化合态两种形式存在，主要矿物有辉锑矿(Sb2S3)和方锑矿(Sb2O3)。在地壳中的丰度为1.0×10-4％。用辉锑矿跟铁屑共热，或用三氧化二锑与碳共热都可还原出锑。
